A Prospective, Randomized Trial Of Simultaneous Pancreatic Cancer Treatment With Enoxaparin and ChemoTherapy (PROSPECT).
Phase of Trial: Phase II/III
Latest Information Update: 12 Jan 2015
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Thromboembolism; Venous thrombosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms PROSPECT
- 04 Jun 2010 Final results presented at the 46th Annual Meeting of the American Society of Clinical Oncology.
- 20 Sep 2009 Results presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology.
- 29 May 2009 Results presented at ASCO 2009.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History